Indication

Malignant esophageal neoplasm

A malignant esophageal neoplasm refers to a primary cancer arising from the mucosal lining of the esophagus, primarily manifesting as either adenocarcinoma or squamous cell carcinoma. Read more about Malignant esophageal neoplasm

27 drugs 27 manufacturers

Advertisement

Drugs that treat it

Common Malignant esophageal neoplasm therapies.

Showing 19–27 of 27 drugs

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
DR.REDDY'S LAB

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
AREVA PHARMACEU

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
AHP

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
SUN PHARMACEUTI

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
LIFESTAR PHARMA

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
QUALLENT PHARMA

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
CIVICASCRIPT, L

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
MYLAN INSTITUTI

CAPECITABINE

5 FLUOROPYRIMIDINES·MALIGNANT ESOPHAGEAL NEOPLASM·+7
BLUEPOINT/ONCOP
Filter & compare in the drug finder →Opens the drug finder with Malignant esophageal neoplasm preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant esophageal neoplasm.

A malignant esophageal neoplasm refers to a primary cancer arising from the mucosal lining of the esophagus, primarily manifesting as either adenocarcinoma or squamous cell carcinoma.

Affecting the upper gastrointestinal tract and predominantly diagnosed in older adults and males, these tumors typically originate in the glandular tissue of the distal esophagus—often secondary to chronic gastroesophageal reflux disease and Barrett esophagus—or in the squamous epithelium of the upper and middle segments.

Pathophysiologically, neoplastic proliferation leads to progressive luminal obstruction and early local invasion through the esophageal wall, characteristically presenting with dysphagia, odynophagia, and unintentional weight loss.

Due to the absence of a true serosal layer and abundant lymphatic drainage, the disease carries a pronounced propensity for rapid transmural extension, regional lymph node involvement, and distant metastasis.

Personalize your experience

Follow Malignant esophageal neoplasm and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it